Delivery Order SPE2DR25D2006-SPE2DR26F58BU

<p>The Defense Logistics Agency issued a $1,276.38 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Xhance 93 mcg nasal spray 16 ml.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 6, 2026. The order carries a ceiling value of $1,276.38 under firm fixed-price terms with no set-aside.</p>

<p>The Defense Logistics Agency issued a $1,102.58 delivery order to AmerisourceBergen Drug Corp on February 11, 2026, for supply of Xhance 93 mcg nasal spray 16 ml.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 12, 2026. The order was issued under firm fixed-price terms with no set-aside applied.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,134.11 to supply Xhance 93 MCG nasal spray (16 mL units) with an ultimate completion date of September 18, 2025. This non-competitive delivery order utilizes firm fixed pricing and was awarded on September 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under a larger indefinite delivery contract...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Xhance 93 microgram nasal spray in 16-milliliter units. This non-set-aside, competitively awarded contract utilizes firm fixed pricing with a ceiling value of $3,180.19 and an ultimate completion date of August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...

The Defense Logistics Agency awarded a delivery order valued at $1,266.79 to AmerisourceBergen Drug Corp for Xhance 93 mcg nasal spray (16ml) on December 4, 2025, with completion scheduled for December 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for Xhance 93 micrograms nasal spray (16 milliliters) with a ceiling value of $3,221.73. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 5, 2025, and performance at the vendor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...

The Defense Logistics Agency awarded a $16,843.25 delivery order to AmerisourceBergen Drug Corp for Xhance 93 mcg nasal spray (16 mL) on December 5, 2025, with an ultimate completion date of December 8, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The order will be performed at AmerisourceBergen's corporate...

The Defense Logistics Agency awarded a delivery order valued at $4,668.46 to AmerisourceBergen Drug Corp for XHANCE 93 MCG Nasal Spray (16ML) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical supplier within the federal medical...

The Defense Logistics Agency awarded a delivery order valued at $2,377.77 to AmerisourceBergen Drug Corp for Xhance 93 microgram nasal spray (16 milliliters) on January 20, 2026, with an ultimate completion date of January 21, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...

The Defense Logistics Agency awarded a delivery order valued at $1,724.52 to AmerisourceBergen Drug Corp for Xhance 93 mcg nasal spray (16mL) on November 7, 2025, with completion targeted for November 10, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal...